Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents - PubMed (original) (raw)
Comparative Study
Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents
Yesim Kaymak et al. Int J Dermatol. 2009 Jan.
Abstract
Background: Since the introduction of isotretinoin to the market, many adverse psychiatric effects, including depression, anxiety and suicide attempts were reported. The aim of this study was to determine whether patients with acne who were treated with isotretinoin experienced significant increases in psychiatric symptoms over a 4-month period compared with patients who received topical acne therapy.
Methods: Seventy-eight acne patients were allocated either to isotretinoin treatment (study group) (n = 37) or to topical treatment (control group) (n = 41). Their psychological status was evaluated at the baseline, second and fourth months of the treatment. All patients were required to complete the dermatology life quality index (DLQI), the Hospital anxiety and depression (HAD) scale, and the beck depression inventory (BDI).
Results: The two groups were not different from each other in terms of DLQI, BDI, HAD-A, HAD-D and total HAD scores at baseline. However, at the end of the second month quality of life was more impaired in the topical treatment group compared to the isotretinoin group (P < 0.05), and there were no difference between two groups in terms of BDI, HAD-A, HAD-D, and total HAD scores (P > 0.05). At the end of fourth month quality of life and all psychological test scores had improved more in the isotretinoin group compared to topical treatment group (P < 0.05).
Conclusion: Results of the present study indicate that there is no increase in depressive and anxiety symptoms in the isotretinoin treatment group compared to that in the topical group. Instead, successful treatment of acne seems to improve both depressive and anxiety symptoms and improve quality of life.
Similar articles
- No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort.
Cohen J, Adams S, Patten S. Cohen J, et al. Can J Clin Pharmacol. 2007 Summer;14(2):e227-33. Epub 2007 Jun 6. Can J Clin Pharmacol. 2007. PMID: 17556790 Clinical Trial. - Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study.
Chia CY, Lane W, Chibnall J, Allen A, Siegfried E. Chia CY, et al. Arch Dermatol. 2005 May;141(5):557-60. doi: 10.1001/archderm.141.5.557. Arch Dermatol. 2005. PMID: 15897376 Clinical Trial. - Disease-specific quality of life is associated with anxiety and depression in patients with acne.
Yazici K, Baz K, Yazici AE, Köktürk A, Tot S, Demirseren D, Buturak V. Yazici K, et al. J Eur Acad Dermatol Venereol. 2004 Jul;18(4):435-9. doi: 10.1111/j.1468-3083.2004.00946.x. J Eur Acad Dermatol Venereol. 2004. PMID: 15196157 - Acne, depression, and suicide.
Hull PR, D'Arcy C. Hull PR, et al. Dermatol Clin. 2005 Oct;23(4):665-74. doi: 10.1016/j.det.2005.05.008. Dermatol Clin. 2005. PMID: 16112443 Review. - Facial edema induced by isotretinoin use: a case and a review of the side effects of isotretinoin.
Scheinfeld N, Bangalore S. Scheinfeld N, et al. J Drugs Dermatol. 2006 May;5(5):467-8. J Drugs Dermatol. 2006. PMID: 16703787 Review.
Cited by
- The occurrence of mental health symptoms in isotretinoin-treated adolescents.
Miller K, McKean A, Hand J, Rackley S, Leung JG, LeMahieu A, Geske J, Bostwick JM. Miller K, et al. Pediatr Dermatol. 2024 Jul-Aug;41(4):635-640. doi: 10.1111/pde.15595. Epub 2024 Mar 18. Pediatr Dermatol. 2024. PMID: 38500340 - Depression, body image and quality of life in acne scars.
Mahajan S, Sawant NS, Mahajan S. Mahajan S, et al. Ind Psychiatry J. 2023 Jul-Dec;32(2):282-287. doi: 10.4103/ipj.ipj_201_22. Epub 2023 Jun 28. Ind Psychiatry J. 2023. PMID: 38161457 Free PMC article. - The Psychological Impact of Isotretinoin Therapy on Acne Vulgaris Patients.
Alamri A, Khafaji R, Balkhy A, Samarkandy S, Alraddadi A. Alamri A, et al. Cureus. 2023 Dec 16;15(12):e50612. doi: 10.7759/cureus.50612. eCollection 2023 Dec. Cureus. 2023. PMID: 38107219 Free PMC article. - Impact of Pediatric Dermatologic Conditions on Child and Parent Quality of Life.
Min M, Malhi JK, Chambers CJ, Sivamani R. Min M, et al. Cureus. 2023 Jul 18;15(7):e42068. doi: 10.7759/cureus.42068. eCollection 2023 Jul. Cureus. 2023. PMID: 37602071 Free PMC article. - A review of psychocutaneous disorders from a psychotherapeutic perspective-Toolkit for the dermatologist.
Zagami M, Klepper E, Wienecke E, Andrzejewski M, Sikder A, Ahmed A, Robinson H. Zagami M, et al. Skin Health Dis. 2023 Jan 9;3(4):e211. doi: 10.1002/ski2.211. eCollection 2023 Aug. Skin Health Dis. 2023. PMID: 37538328 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical